Potential Link Between Regular Opioid Use and Increased Dementia Risk
New research associates regular opioid consumption with a higher risk of dementia and brain volume reduction, emphasizing cautious opioid prescribing for chronic pain management.
Recent research published in Alzheimer's & Dementia reveals a significant association between consistent opioid use and a heightened risk of developing dementia, especially vascular dementia. Led by Dr. Sha Feng from the Shenzhen Institute of Advanced Technology and collaborating with experts from Massachusetts Veterans Home and the University of Pennsylvania, the study highlights critical insights into how opioids may influence cognitive health.
Chronic non-cancer pain (CNCP), a condition persisting for over three months unrelated to cancer, saw widespread opioid prescriptions starting in the mid-1990s. This increase has raised concerns over dependence, misuse, and potential neurological impacts. Existing evidence suggests that opioids can alter the brain's endogenous opioid system and impair regions such as the hippocampus, which are vital for cognitive function.
The study analyzed data from 197,673 UK Biobank participants aged between 37 and 73 years over an average follow-up period of nearly 14 years. Employing advanced statistical models to control for confounding factors, researchers found that individuals who regularly used opioids faced a 20% higher overall risk of developing dementia compared to non-opioid analgesic users. Those on high-potency opioids faced an even greater risk, exceeding 70%. Conversely, individuals taking non-opioid painkillers showed dementia risk comparable to those not using opioids.
Neuroimaging assessments further revealed that regular, strong opioid use was associated with reductions in total brain volume, white matter, and hippocampal size—regions crucial for memory and cognition. Additionally, regular opioid use was linked to decreased fluid intelligence, although no significant decline was observed in prospective memory.
These findings underscore the importance of evaluating opioid potency and cumulative exposure when considering risks related to cognitive decline. The research underscores the necessity for cautious opioid prescribing, especially for long-term pain management, to mitigate potential adverse effects on brain health.
Source: https://medicalxpress.com/news/2025-07-regular-opioid-dementia.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Alarming Rise in Violence and Neglect of Elderly with Dementia at Home
A comprehensive study uncovers alarming levels of violence, abuse, and neglect among elderly dementia patients living at home, highlighting systemic failures and urgent need for better support.
Revolutionizing Blood Transfusion Standards: How Research is Saving Lives
New research by Dr. Jeffrey Carson is transforming blood transfusion guidelines, especially for heart attack patients, potentially saving thousands of lives annually while optimizing blood use.
Research Highlights Dosing Challenges of Common Anticoagulants in Underserved Communities
A recent study reveals significant dosing and prescribing issues with common anticoagulants in underserved communities, emphasizing the need for improved patient safety measures and stewardship programs.
